BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210125T153000
DTEND;TZID=America/New_York:20210125T170000
DTSTAMP:20260408T152325
CREATED:20210119T144639Z
LAST-MODIFIED:20210119T144740Z
UID:13114-1611588600-1611594000@www.masslifesciences.com
SUMMARY:University of Massachusetts Advanced Manufacturing zoom summit
DESCRIPTION:Join us to engage in a discussion of research and development in Advanced Manufacturing at UMass. \nThe University of Massachusetts “zoom summit” in Advanced Manufacturing will introduce industry leaders\, their colleagues in business strategy and government relations\, to some of the most important breakthroughs of recent years in three key fields in advanced manufacturing. \nIn the final hour\, we invite you to discuss grand challenges that will shape this field in the next decade. Accomplished scientists\, from across the five campuses of the University of Massachusetts will be on hand to discuss the most pressing translational questions in the post-COVID period. \nBreakout groups: \n1. Manufacturing 2030: agile\, responsive\, instant\, customized\, adaptive\, collaborative robots in manufacturing \n2 Manufacturing 2030: Green/Sustainable manufacturing\, integration of biological and non-biological manufacturing \n3. Manufacturing 2030: 3D Printing and Roll to roll on an industrial scale
URL:https://www.masslifesciences.com/event/university-of-massachusetts-advanced-manufacturing-zoom-summit/
LOCATION:Online\, online
ORGANIZER;CN="University of Massachusetts":MAILTO:ccarragher@umassp.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210121T120000
DTEND;TZID=America/New_York:20210121T130000
DTSTAMP:20260408T152325
CREATED:20201224T180811Z
LAST-MODIFIED:20201224T180811Z
UID:12913-1611230400-1611234000@www.masslifesciences.com
SUMMARY:Key Considerations for Medical Device Cloud Connectivity
DESCRIPTION:Medical devices are becoming increasingly cloud-connected. What used to be a technology only deployed by large well-funded companies is now becoming a core requirement of many medical device startups. Cloud connectivity in medical devices can be a complicated and risky process. In this presentation\, Abbas Dhilawala\, CTO of Galen Data\, will describe the core software\, hardware\, and regulatory considerations critical for success. For companies developing devices with a cloud dependency\, investors in medical device companies\, or those who have a general interest in medical device innovation\, please join us for this informative webinar and Q&A session. \nAbbas Dhilawala is the CTO of Galen Data\, leaders in medical device cloud connectivity. Abbas has over 17 years of experience developing enterprise-grade software for the medical device industry. He is well versed with technology and industry standards regulating security and privacy of data. His expertise lies in programming\, cloud\, cybersecurity\, data storage and regulated medical device software. Prior to Galen Data\, Abbas worked as a Software Architect at Tietronix Software\, where he led technical teams in creating medical device software that were successfully cleared for FDA Class I\, II and III and CE Marking. Abbas has a Master’s Degree in Software Engineering from University of Houston – Clear Lake\, and a Bachelor’s Degree in Information Technology from North Gujarat University\, India.
URL:https://www.masslifesciences.com/event/key-considerations-for-medical-device-cloud-connectivity/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210119T120000
DTEND;TZID=America/New_York:20210119T130000
DTSTAMP:20260408T152325
CREATED:20201224T180909Z
LAST-MODIFIED:20201224T180909Z
UID:12912-1611057600-1611061200@www.masslifesciences.com
SUMMARY:BYO Lunch & Learn: Venture Financing 101
DESCRIPTION:During this virtual BYO Lunch & Learn you will learn the basics about how medical device & biotech ventures get financed and how that impacts your company and you as an individual. Various topics will be covered\, including: \n– The importance of planning \n– Pitching to investors \n– What investor types to target/prioritize and their link to company stage and strategy \n– How dilution and vesting can impact you personally \nBill Yelle: Entrepreneur in Residence\, Partners Innovation Fund \nBill is both an Entrepreneur in Residence at MGH-Brigham Innovation and an Adjunct Faculty Member at The Manning School of Business at UMass Lowell. Bill has over 30 years of experience in the biopharmaceutical industry\, ranging from large pharma to early stage\, venture-backed companies. He currently serves as founding CEO of FireCyte Therapeutics\, a neuro-ophthalmology spinout of Mass Eye and Ear Institute. Previously\, Bill was Executive Chairman of Envisia Therapeutics. Prior to Envisia\, Bill served as CEO of Aldea Pharmaceuticals\, where he successfully completed a Series B raise and brought two programs into the clinic. Prior to Aldea\, he was Senior Vice President of Corporate Development and Licensing for Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.)\, where he was responsible for the consummation of over 30 material transactions\, the most notable being the company’s sale to Dainippon Sumitomo Pharma for $2.6 billion in 2009. Bill was also instrumental in Sepracor’s transition from an early stage clinical organization into a fully integrated pharmaceutical company. Prior to joining Sepracor in 1995\, Bill held various positions of increasing responsibility in Pfizer’s U.S. Pharmaceuticals Group. \nIn addition to serving on the board of the Jack M. Wilson Center for Entrepreneurship\, prior board assignments include Envisia Therapeutics\, LQ3 Pharma and Aldea Pharmaceuticals. \nBill has an M.B.A. in Management/Marketing from Columbia University\, an M.S. in Organic Chemistry from the University of California at Berkeley and a B.S. Cum Laude from the University of Massachusetts Lowell.
URL:https://www.masslifesciences.com/event/byo-lunch-learn-venture-financing-101/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210114T120000
DTEND;TZID=America/New_York:20210114T130000
DTSTAMP:20260408T152325
CREATED:20201224T181027Z
LAST-MODIFIED:20201224T181027Z
UID:12911-1610625600-1610629200@www.masslifesciences.com
SUMMARY:Waters PREMIER: High Performance Surfaces to Address Metal-Based Secondary
DESCRIPTION:The use of metal hardware for chromatographic systems and columns dates back to the advent of high-performance liquid chromatography. Metal alloys such as stainless steel\, titanium and MP35N are routinely used for chromatographic hardware – where stainless steel has become a material of choice for constructing LC columns. While these choices in hardware materials afford high pressure capabilities and low-cost manufacturability\, they also can negatively impact analyte recovery and peak shape. These complications stem from electrostatic effects\, electron sharing and Lewis acid-base interactions. The longstanding complication of adsorption of analytes with electron rich moieties has led to a variety of workarounds – reliance on chelating buffers and additives\, sample derivatization techniques\, system priming or passivation as well as utilization of non-metallic surfaces (e.g. polyether ether ketone). Unfortunately\, such work arounds often sacrifice capabilities such as MS compatibility\, high pressure capabilities or drive workflows to complicated methodologies with multicomponent mobile phases or stringent system treatment protocols. In order to address metal-based secondary interactions in LC and LC-MS analyses without the aforementioned performance compromises\, we have developed specialized inert LC surface which provide substantial improvements in sample recovery and peak shape. These benefits have been demonstrated for a variety of analytes\, including small molecule metabolites\, phosphor-sugars\, oligonucleotides\, glycans and peptides. \nChemistry Operations\, Waters Corporation\, Milford\, MA\, USA \nBonnie Alden\, Jon Belanger\, Kenneth Berthelette\, Robert Birdsall\, Cheryl Boissel\, Mathew DeLano\, Michael Donegan\, Martin Gilar\, Paula Hong\, Moon Chul Jung\, Mary Lame\, Matthew A. Lauber\, Thomas McDonald\, Jennifer Nguyen\, Amit Patel\, Paul Rainville\, Jennifer Simeone\, Kerri Smith\, Thomas Walter\, Kevin Wyndham
URL:https://www.masslifesciences.com/event/waters-premier-high-performance-surfaces-to-address-metal-based-secondary/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210113T183000
DTEND;TZID=America/New_York:20210113T200000
DTSTAMP:20260408T152325
CREATED:20210111T213153Z
LAST-MODIFIED:20210111T213153Z
UID:13035-1610562600-1610568000@www.masslifesciences.com
SUMMARY:Resolutions and Reflections Happy Hour
DESCRIPTION:Join us for Women Accelerator’s January Happy Hour Event – Resolutions and Reflections! This is a virtual “Bring Your Own Beverage” networking event hosted by Women Accelerators. \n2020 was a struggle of a year in so many ways. As much as we would like to think that all stayed behind us when the clock hit midnight on December 31\, unfortunately life does not work that way. The best way to move forward and grow is to reflect on where we’ve been\, what we learned\, and how we can do better going forward. \nGrab your favorite beverage and join us to ring in the New Year as we reflect and set intentions! \nCheers\, \nThe Women Accelerators Team \nEveryone is welcome to join this event! \n*** \nVanessa Chumbley\, our Events and Programs Coordinator\, is going to be your host this time. \n*** \nDate/Time: Wednesday\, January 13th\, 2021\, 6:30-8:00 PM EST \nZoom link will be sent on the day of the event. \n*** \nWomen Accelerators is a nonprofit organization that promotes the advancement of women. We host monthly seminars and discussions to give women the help they need to succeed.
URL:https://www.masslifesciences.com/event/resolutions-and-reflections-happy-hour/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210113T160000
DTEND;TZID=America/New_York:20210113T180000
DTSTAMP:20260408T152325
CREATED:20210111T213256Z
LAST-MODIFIED:20210111T213256Z
UID:12992-1610553600-1610560800@www.masslifesciences.com
SUMMARY:BioXchange - The What\, When’s\, and Why’s of Debt Financing Solutions
DESCRIPTION:Attend BioXchange during the annual J.P.Morgan Healthcare Conference: Jan 13th from 4-6PM EST. Sponsored by Cambridge Trust. \nWe are excited to partner with Cambridge Trust to invite you to BioXchange’s first annual J.P. Morgan Healthcare Conference event. We have a dynamic panel of expert investors and debt providers to discuss hot topics and innovation opportunities across life sciences and healthcare. Join our discussion to learn more about how entrepreneurs are raising capital and strategically using debt\, what is the proper use and timing for venture debt\, along with the overall benefits of using venture debt. We are excited to provide a year in review of 2020\, forward projections for 2021\, along with an investor’s perspective regarding the new presidency and effects from the pandemic. \nThe panel discussion will take place on Zoom. Networking will proceed afterwards the discussion on Grapevine Network for all those interested. We hope to see you there! \nPanelists include:\nTroy Zander – Partner – Barnes & Thornburg LLP\nBarnes & Thornburg LLP is a full-service firm advising on legal matters that span state lines and across borders. The firm serve clients worldwide from 19 U.S. offices; as one of the 100 largest firms in the nation\, B&T has experience in virtually all the legal practice areas required to do business in today’s global marketplace. Troy Zander leads the firm’s Venture Lending Practice\, principally representing lenders to technology and life science companies\, and their venture capital and private equity sponsors. \nDan Batdorf – Sales Director – Farnam Street Financial\nFarnam Street Financial specializes in designing customized lease financing solutions for companies acquiring technology and business essential assets. We are privately held\, use our own capital and have never sold off a lease. Our unique approach of direct origination and retention of lease ownership allows us to provide the lowest cost\, highest value leasing solutions to our customers. \nTim Scallen – Managing Partner – BSC Capital Partners\nBailey Southwell & Co. (BSC) Capital Partners is a partner-owned investment bank providing M&A and growth capital advisory services for middle-market healthcare and tech-enabled services businesses. Our deep sector focus provides clients both real-time industry insights and the most extensive network of investors across the capital stack to guarantee the best outcome by customizing the right approach for each process. \nMishone Donelson – Managing Director – Horizon Technology Finance\nHorizon Technology Finance is a leading venture lending platform that thoughtfully and creatively provides structured debt products to life science and technology companies. Horizon’s experienced team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have\, collectively\, originated and invested more than $5 billion in venture loans to thousands of companies. Since 2004\, Horizon has directly originated and invested more than $2 billion in venture loans to more than 250 growing companies. \nMore information regarding our sponsor: \nSupporting Life Sciences Innovation—from Idea to Exit\nCambridge Trust is the only locally based bank with a group focused solely on the financial needs of life sciences companies. Our team has deep roots and years of experience working with these businesses. By applying our industry-specific financial and strategic expertise to the unique challenges these companies face\, we create customized banking and financing solutions for their specialized needs.
URL:https://www.masslifesciences.com/event/bioxchange-the-what-whens-and-whys-of-debt-financing-solutions/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210113T100000
DTEND;TZID=America/New_York:20210113T113000
DTSTAMP:20260408T152325
CREATED:20201124T160232Z
LAST-MODIFIED:20201124T160320Z
UID:12766-1610532000-1610537400@www.masslifesciences.com
SUMMARY:Panel 2: Data Science Education Policy Support
DESCRIPTION:Panel 2 Guiding Questions: ​\nHow can existing policies be ​best utilized to expand the size and diversity of high school to ​post-secondary Data Science programs? Are any new ​policies needed?​ \nPanelists\nModerator\, To Be Announced\nElizabeth Bennett\, Mass DESE\nDavid Cedrone\, Mass Department of Higher Education\nRobert LePage\, Executive Office of Education\nTom Sannicandro\, Mass Association of Community Colleges \nExpanding Access to Data Science Careers \nEach discussion in the panel series will address a key component critical to the development of a strategic plan to extend and expand the early-stage Data Science pipeline: \n\nTo understand the need for a career pathway that begins with high school and community college students.\nTo review existing policies in Massachusetts that support efforts to prepare more students for Data Science careers\, and discuss what additional policy support might be needed.\nTo learn from programs that broaden participation in other disciplines and apply those best practices in developing outreach and support programs for a more diverse community of students.\nTo discover current initiatives for high school and community college students and discuss how they may form the basis of the early-stage Data Science pipeline.
URL:https://www.masslifesciences.com/event/panel-2-data-science-education-policy-support/
LOCATION:Online\, online
ORGANIZER;CN="Education Development Center":MAILTO:datascience@edc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210112T120000
DTEND;TZID=America/New_York:20210112T130000
DTSTAMP:20260408T152325
CREATED:20201224T181004Z
LAST-MODIFIED:20201224T181004Z
UID:12910-1610452800-1610456400@www.masslifesciences.com
SUMMARY:Virtual BYO Lunch & Learn: Connecting Startups to the Regional Supply Chain
DESCRIPTION:Are you a startup with a physical product or component? Are you looking for assistance in navigating manufacturing\, supply chain\, and the path to scaling your idea? Are you curious about how to access free curated connections with suppliers\, office hours\, webinars\, and more? \nPlease join us on January 5th at 12pm for Connecting Startups to the Regional Supply Chain – a session designed to help startups like you learn about FORGE as a nonprofit resource\, the importance of manufacturing locally\, and how FORGE can help you scale! \nThis interactive session is open to any and all startups with physical products or components\, and will be led by Anya Losik\, Program Manager at FORGE.
URL:https://www.masslifesciences.com/event/virtual-byo-lunch-learn-connecting-startups-to-the-regional-supply-chain/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210112T120000
DTEND;TZID=America/New_York:20210112T130000
DTSTAMP:20260408T152325
CREATED:20201207T161853Z
LAST-MODIFIED:20201207T161853Z
UID:12815-1610452800-1610456400@www.masslifesciences.com
SUMMARY:Connecting Startups to the Regional Supply Chain
DESCRIPTION:Are you a startup with a physical product or component? Are you looking for assistance in navigating manufacturing\, supply chain\, and the path to scaling your idea? Are you curious about how to access free curated connections with suppliers\, office hours\, webinars\, and more? \nPlease join us on January 5th at 12pm for Connecting Startups to the Regional Supply Chain – a session designed to help startups like you learn about FORGE as a nonprofit resource\, the importance of manufacturing locally\, and how FORGE can help you scale! \nThis interactive session is open to any and all startups with physical products or components\, and will be led by Anya Losik\, Program Manager at FORGE.
URL:https://www.masslifesciences.com/event/connecting-startups-to-the-regional-supply-chain/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210105T120000
DTEND;TZID=America/New_York:20210105T130000
DTSTAMP:20260408T152325
CREATED:20201207T162209Z
LAST-MODIFIED:20201207T162209Z
UID:12810-1609848000-1609851600@www.masslifesciences.com
SUMMARY:Connecting Startups to the Regional Supply Chain
DESCRIPTION:Are you a startup with a physical product or component? Are you looking for assistance in navigating manufacturing\, supply chain\, and the path to scaling your idea? Are you curious about how to access free curated connections with suppliers\, office hours\, webinars\, and more? \nPlease join us on January 5th at 12pm for Connecting Startups to the Regional Supply Chain – a session designed to help startups like you learn about FORGE as a nonprofit resource\, the importance of manufacturing locally\, and how FORGE can help you scale! \nThis interactive session is open to any and all startups with physical products or components\, and will be led by Anya Losik\, Program Manager at FORGE.
URL:https://www.masslifesciences.com/event/connecting-startups-to-the-regional-supply-chain-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201217T120000
DTEND;TZID=America/New_York:20201217T123000
DTSTAMP:20260408T152325
CREATED:20201029T193919Z
LAST-MODIFIED:20201029T193919Z
UID:12650-1608206400-1608208200@www.masslifesciences.com
SUMMARY:US Health Policy After the 2020 Election
DESCRIPTION:In this Harvard Medical School webinar\, Harvard Medical School physician and health economist Zirui Song\, MD\, PhD\, will discuss how the 2020 election will have profound effects on the direction of U.S. health policy. Dr. Sing will outline the potential implications of the election results on health insurance coverage\, payment policy for health care providers\, and key considerations for the Medicare and privately-insured population.
URL:https://www.masslifesciences.com/event/us-health-policy-after-the-2020-election/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201216T160000
DTEND;TZID=America/New_York:20201216T190000
DTSTAMP:20260408T152325
CREATED:20201130T192505Z
LAST-MODIFIED:20201130T192505Z
UID:12799-1608134400-1608145200@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event is being powered on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to check in and out of different group discussions through an interactive chatroom environment. This platform provides the closest experience to an actual networking event since the pandemic hit. \nYou are welcome to jump in on the event at any point of time. The event will run as long as people are within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-3/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201215T160000
DTEND;TZID=America/New_York:20201215T180000
DTSTAMP:20260408T152325
CREATED:20201104T140342Z
LAST-MODIFIED:20201104T140342Z
UID:12695-1608048000-1608055200@www.masslifesciences.com
SUMMARY:Free "Barracuda Bowl" Pitch Event
DESCRIPTION:Several entrepreneurs will face tough questions from a panel of investors regarding their technologies\, current stage of development\, and financial projections in a “Shark Tank” style pitch event. \nThis event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area \nThis year the focus is on:\nAlternative vaccine delivery\nMonitoring: Post-operative patient monitoring (soft tissue and orthopedic focused) & remote monitoring \nHeld Virtually via WebEx
URL:https://www.masslifesciences.com/event/free-barracuda-bowl-pitch-event/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201214T090000
DTEND;TZID=America/New_York:20201218T113000
DTSTAMP:20260408T152325
CREATED:20200825T132809Z
LAST-MODIFIED:20200825T132809Z
UID:12219-1607936400-1608291000@www.masslifesciences.com
SUMMARY:Advancing Leadership Skills\, For Experienced Managers (December)
DESCRIPTION:This interactive online course\, held over three sessions\, focuses on how leaders can drive performance and positively shape the culture of the workplace to maximize employee and stakeholder engagement. Participants engage in activities and learn the skills needed to address common coaching challenges. Approaches for building high performing teams are also investigated. A roadmap for effective remote team communication is reviewed to enable managers to maintain the same level of connection\, inclusivity\, and accountability\, with a focus on how to facilitate productive remote meetings. \nCourse Objectives: \nConsider specific actions leaders can take to help build and shape a more engaging work environment.\nReview key coaching principles and how they can be applied to typical coaching challenges.\nBecome versed in the Seven Principles of Remote Team Communication.\nIncorporate innovative best practices for facilitating remote collaboration.\nReinforce the importance of building mutual trust in relationships\, on teams and across an organization to foster free expression and build a “One Team” culture.\nLearn ways to foster more constructive conflict and better manage interpersonal conflict.\nReview a framework for creating leadership development goals as an individual guide. \nCourse Schedule:\nMonday\, December 14th\, 2020 9:00 AM – 11:15 PM\nTuesday\, December 16th\, 2020 9:00 AM – 11:15 PM\nFriday\, December 18th\, 2020 9:00 AM – 11:15 PM
URL:https://www.masslifesciences.com/event/advancing-leadership-skills-for-experienced-managers-december/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201210T121500
DTEND;TZID=America/New_York:20201210T133000
DTSTAMP:20260408T152325
CREATED:20201125T173021Z
LAST-MODIFIED:20201125T173114Z
UID:12787-1607602500-1607607000@www.masslifesciences.com
SUMMARY:Accelerating Breakthroughs in the Life Sciences: Insights from MassNext Gen Awardees
DESCRIPTION:The Massachusetts Life Sciences Center (MLSC) offers programs that fund innovation\, research and development\, commercialization\, and manufacturing activities in the fields of biopharma\, medical device\, diagnostics\, and digital health\, as well as innovation-driven economic and workforce development initiatives in Massachusetts. \nMassachusetts Next Generation Initiative (MassNextGen) is a five-year\, $2 million+ commitment to ensure greater gender parity in the next generation of life science entrepreneurs. Women-led early-stage life science companies will be awarded a year-long customized package of support\, to include grant funding and access to coaching on business strategy and raising capital. Applications will open in January and close on Friday\, February 12. \nThis seminar is designed to help you learn whether initiatives offered by the MLSC are right for you\, and to share insights from MassNextGen awardees on their journeys as entrepreneurs. \nModerator:\nLi Liang\, Managing Director\, BUild Lab IDG Capital Student Innovation Center \nPanel participants: \n\nJennifer Griffin\, PhD\, VP Industry Strategy and Investments\, MLSC\nCamille Martin\, PhD\, CEO and Co-Founder\, Seaspire Skincare\nMin Min Yen\, PhD\, CEO and Co-Founder\, PhagePro\nVirginia Burger\, PhD\, Co-Founder and CEO\, New Equilibrium Biosciences\nElizabeth O’Day\, PhD\, CEO and Founder\, Olaris\, Inc.
URL:https://www.masslifesciences.com/event/12787/
LOCATION:Online\, online
ORGANIZER;CN="Boston University Technology Development":MAILTO:otd@bu.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201209T130000
DTEND;TZID=America/New_York:20201209T140000
DTSTAMP:20260408T152325
CREATED:20201207T161834Z
LAST-MODIFIED:20201207T161834Z
UID:12817-1607518800-1607522400@www.masslifesciences.com
SUMMARY:LET’S TALK ABOUT: THE RIGHT TRACK Increasing Inclusivity in 2021
DESCRIPTION:LaunchBio’s Let’s Talk About series aims to inform\, educate\, and provide actionable takeaways for increasing diversity\, equity\, and inclusivity (DE&I) in the life sciences. Let’s get your company prepared for 2021! This month we have invited industry experts to share the actions they’ve taken to make the workplace more inclusive. In this session you will learn: \nHow to start a DE&I program\nInitiatives that advance Inclusivity\nGetting employees involved\nSetting DE&I goals for your company
URL:https://www.masslifesciences.com/event/lets-talk-about-the-right-track-increasing-inclusivity-in-2021/
LOCATION:Zoom
ORGANIZER;CN="LaunchBio":MAILTO:joan@launchbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201209T100000
DTEND;TZID=America/New_York:20201209T113000
DTSTAMP:20260408T152325
CREATED:20201124T155720Z
LAST-MODIFIED:20201124T160341Z
UID:12764-1607508000-1607513400@www.masslifesciences.com
SUMMARY:Panel 1: The Data Science Workforce Challenge
DESCRIPTION:Panel 1 Guiding Question: ​\nWhy is the development of targeted career pathways for high school and community college an essential strategy for expanding access to Data Science careers?​ \nPanelists\nModerator\, Karla Talanian\, MassBioEd\nSudeshna Das\, Mass General Hospital\nShuba Gopal\, Broad Institute\nIain McFadyen\, LifeMine Theraputics\nSally Trabucco\, Foundation Medicine\n \nExpanding Access to Data Science Careers \nEach discussion in the panel series will address a key component critical to the development of a strategic plan to extend and expand the early-stage Data Science pipeline: \n\nTo understand the need for a career pathway that begins with high school and community college students.\nTo review existing policies in Massachusetts that support efforts to prepare more students for Data Science careers\, and discuss what additional policy support might be needed.\nTo learn from programs that broaden participation in other disciplines and apply those best practices in developing outreach and support programs for a more diverse community of students.\nTo discover current initiatives for high school and community college students and discuss how they may form the basis of the early-stage Data Science pipeline.
URL:https://www.masslifesciences.com/event/panel-1-the-data-science-workforce-challenge/
LOCATION:Online\, online
ORGANIZER;CN="Education Development Center":MAILTO:datascience@edc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201208T100000
DTEND;TZID=America/New_York:20201208T110000
DTSTAMP:20260408T152325
CREATED:20201120T153912Z
LAST-MODIFIED:20201120T153912Z
UID:12754-1607421600-1607425200@www.masslifesciences.com
SUMMARY:BioPharma Manufacturing In Massachusetts: A Talent Powerhouse Continues To Fuel Growth
DESCRIPTION:Massachusetts has long been the epicenter of biopharma research and development. Years of investment and collaboration between industry\, education\, and government has provided biopharma manufacturers a rich and deep talent landscape in Massachusetts. Join leaders in the biopharma industry and higher education as they discuss current talent development assets\, share initiatives to grow talent even further\, and look to the future as the industry continues its growth in Massachusetts. \nThis virtual Forum\, hosted in partnership by MassBio\, MassECON\, MassBioEd\, and the Massachusetts Life Sciences Center\, will include an overview of current biopharma talent assets and how the pool of talent has grown in recent years\, followed by an industry-higher education panel that will share case studies in collaboration and insights on what is on the horizon for new talent development. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://www.masslifesciences.com/event/biopharma-manufacturing-in-massachusetts-a-talent-powerhouse-continues-to-fuel-growth/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201207T130000
DTEND;TZID=America/New_York:20201211T153000
DTSTAMP:20260408T152325
CREATED:20200825T133623Z
LAST-MODIFIED:20200825T133623Z
UID:12216-1607346000-1607700600@www.masslifesciences.com
SUMMARY:Business Of Biotech 101
DESCRIPTION:This MassBioEd online course explores the business considerations that drive company strategies. Participants are provided with an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. Students will be provided foundational information about the BioPharma industry and regulation via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share\, phases of development\, patient population\, and safety profile. Guest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will embark upon a high-level overview of Research and Development\, including pre-clinical through market approval. \nCourse Schedule: \nMonday\, December 7th\, 2020\, 1:00 PM – 3:30 PM\nWednesday\, December 9th\, 2020\, 1:00 PM – 3:30 PM\nFriday\, December 11th\, 2020\, 1:00 PM – 3:30 PM
URL:https://www.masslifesciences.com/event/business-of-biotech-101/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201207T100000
DTEND;TZID=America/New_York:20201211T120000
DTSTAMP:20260408T152325
CREATED:20201123T161529Z
LAST-MODIFIED:20201123T161529Z
UID:12753-1607335200-1607688000@www.masslifesciences.com
SUMMARY:Medical Device Development Immersion Class
DESCRIPTION:This multi-day workshop\, from MassMEDIC and Biotech Primer\, will help you onboard employees new to medtech with a step-by-step guide to the basics of medical device development. Classes will be held over multiple days. \nMedical Device Development Immersion is a ten-hour course that surveys all aspects of medical device development. Learn about the changing regulatory environment and compare the United States and European Union approval processes. Discover in detail the five phases of medical device development: market opportunity\, evaluation\, design\, verification\, and manufacturing. Take this course to develop an understanding of the entire process required to bring a new medical device to market. \nWho should attend: Anyone who works in medicine\, engineering\, finance\, legal\, marketing\, business development\, project management\, IT\, administrative support\, quality assurance\, regulatory affairs\, and manufacturing. \nWhat you’ll get from attending the class: \n-Improved ability to communicate with engineers\, colleagues\, regulators and manufacturers \n-Fluency in medical device terminology\, acronyms\, and processes \n-In depth understanding of the five steps used in medical device development \n-Regulatory criteria to determine if a product is a Class I\, Class II\, Class III medical device \n-Strategy to mitigate risk during medical device development
URL:https://www.masslifesciences.com/event/medical-device-development-immersion-class/
LOCATION:Online\, online
ORGANIZER;CN="MassMEDIC":MAILTO:info@massmedic.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201207T090000
DTEND;TZID=America/New_York:20201211T111500
DTSTAMP:20260408T152325
CREATED:20200825T133707Z
LAST-MODIFIED:20200825T133707Z
UID:12213-1607331600-1607685300@www.masslifesciences.com
SUMMARY:Transitioning To Leader\, For New Managers (December)
DESCRIPTION:Participants of this course will gain a clear understanding of the leader-manager they aim to be and the essential skills and strategies to help them get there. This interactive online course focuses on fundamentals for interviewing and hiring\, and strategies for how to develop employees and set them up for success. Other topics of discussion include approaches to effective communication and how to foster collaboration among teams\, both remotely and in-person. \nCourse Objectives: \nGain insight into the interdependence of leadership and management in your role and learn how to become an effective leader-manager.\nUnderstand how to lead behavioral-based interviews and achieve valuable outcomes in hiring.\nBecome confident in setting employees up for success and understand the key principles in managing performance and delivering feedback.\nDiscover how to create a collaborative agenda for remote and in-person meetings\nEnhance the impact of teamwork by reviewing the five qualities of effective remote collaboration\nIdentify specific actions you can take to build trust and psychological safety with direct reports and other key relationships.\nDevelop increased awareness of the trade-offs associating in various communication choices.\nLearn approaches to fostering collaboration across a group or team. \nCourse Schedule: \nMonday\, December 7th\, 2020 9:00 AM – 11:15 AM\nWednesday\, December 9th\, 2020 9:00 AM – 11:15 AM\nFriday\, December 11th\, 2020 9:00 AM – 11:15 AM
URL:https://www.masslifesciences.com/event/transitioning-to-leader-for-new-managers-december/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201204T080000
DTEND;TZID=America/New_York:20201204T093000
DTSTAMP:20260408T152325
CREATED:20201130T192721Z
LAST-MODIFIED:20201130T192721Z
UID:12794-1607068800-1607074200@www.masslifesciences.com
SUMMARY:Chile & Massachusetts Bilateral collaboration supporting life science innovation
DESCRIPTION:The ChileMass Ignite webinar\, organized by MassNex and ChileMass\, aims to show the American and Chilean public the capabilities and potential to carry out joint projects between Chile and Massachusetts\, especially focused on life sciences. \nWe will have four amazing speakers\, two from MA and two from Chile. \nMA:\nJeffrey Sanchez\, Senior Advisor\, Rasky Partners; Former Chair of the Ways and Means Committee of the Massachusetts House of Representatives\, and Senior Advisor at Rasky Partners\, focusing on strategic and political advising and impact leadership.\nCarolina Alarco\, Founder and Principal\, Bio Strategy Advisors LLC\, Founding Venture Partner\, AccelHUB and co-founder and member of the Steering Committee of Latinos in Bio. \nCHILE:\nJulio Pertuzé\, Undersecretary of Economy of the Government of Chile\, PhD from MIT. Chile as a natural development platform for new innovations.\nPatricia Jorquera\, Senior Scientist at Moderna Therapeutics\, she is an expert in respiratory viruses specializing in vaccine development. \n*Note: While this event is virtual\, space is limited. Please register for the event on the Zoom meeting registration: https://zoom.us/meeting/register/tJcpfu-tqTwqHtW5UwQIYvf475X6XZpwbZO1
URL:https://www.masslifesciences.com/event/chile-massachusetts-bilateral-collaboration-supporting-life-science-innovation/
LOCATION:Online\, online
ORGANIZER;CN="Massnex":MAILTO:rschultz@massnex.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T090000
DTEND;TZID=America/New_York:20201208T113000
DTSTAMP:20260408T152325
CREATED:20200825T133227Z
LAST-MODIFIED:20200825T133227Z
UID:12236-1606986000-1607427000@www.masslifesciences.com
SUMMARY:Science Of Biotech 101 (December)
DESCRIPTION:This online course is designed for the non-scientists as a survey of the basic biological processes that are foundational to the Biopharma and life sciences industry. You will apply your new understanding of basic cell and molecular biology to the work of most life sciences companies that research and develop therapies and products that improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSession 1: \nIntroductions\nIndustry Overview\nThe Raw Materials of Biotechnology: Protein and Cells\nIndustry Applications: The Raw Materials of Biotechnology: DNA\nSession 2: \nMolecular Biology: From DNA to Protein\nGenetics: Chromosomes\, Genes and Genomes\nIndustry Applications\nSession 3: \nGenetic Engineering\nThe Immune System\nIndustry Applications: Mitigating Disease\nCourse Schedule:\nThursday\, December 3rd\, 2020 9:00-11:30 AM\nFriday\, December 4th\, 2020 9:00-11:30 AM\nTuesday\, December 8th\, 2020 9:00-11:30 AM
URL:https://www.masslifesciences.com/event/science-of-biotech-101-december/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201202T140000
DTEND;TZID=America/New_York:20201202T150000
DTSTAMP:20260408T152325
CREATED:20201123T162122Z
LAST-MODIFIED:20201123T162122Z
UID:12733-1606917600-1606921200@www.masslifesciences.com
SUMMARY:Addressing Health Disparities: Clinical Insights on Race and Social Justice
DESCRIPTION:International Medical Graduates Providing Care to Underserved and Eliminating Health Disparities \nPlease join us for this important discussion on the role of international medical graduates in providing care to the underserved. \nWe will feature HMS faculty presentations with perspectives on clinical management and health care disparities. Register to receive login access\, as well as recordings of the sessions after they air. Continuing education credits will be available.
URL:https://www.masslifesciences.com/event/addressing-health-disparities-clinical-insights-on-race-and-social-justice/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201202
DTEND;VALUE=DATE:20201206
DTSTAMP:20260408T152325
CREATED:20200416T181710Z
LAST-MODIFIED:20210114T204639Z
UID:11573-1606867200-1607212799@www.masslifesciences.com
SUMMARY:Global Clinical Scholars Research Training Certificate Program
DESCRIPTION:A one-year program\, GCSRT combines online learning with three intensive\, residential workshops that are designed to offer a mix of traditional and innovative approaches. Each month\, you will participate in five to six interactive webinars – including review sessions by faculty and special seminars from leading experts–and also have access to more than 85 prerecorded online lectures.
URL:https://www.masslifesciences.com/event/global-clinical-scholars-research-training-certificate-program/
LOCATION:Harvard Medical School\, 4 Blackfan St\, 4th floor\, Boston\, United States
ORGANIZER;CN="Harvard Medical School External Education":MAILTO:sqil@hms.harvard.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T130000
DTEND;TZID=America/New_York:20201208T153000
DTSTAMP:20260408T152325
CREATED:20201019T214202Z
LAST-MODIFIED:20201019T214202Z
UID:12577-1606827600-1607441400@www.masslifesciences.com
SUMMARY:Presenting With Persuasion\, Clarity & Strength
DESCRIPTION:The ability to speak in a clear\, comfortable\, and confident manner is a key skill for all biotech industry professionals. Whether presenting internally to a small group of peers\, entire departments\, management\, or externally to clinicians\, patient advocates\, other medical professionals\, the press\, or investors\, telling your story effectively\, delivering meaningful messages\, being persuasive\, and speaking confidently in a variety of settings takes skill development and practice. The workshop will be interactive\, with practice\, role playing\, and exercises. Combining this approach with a comprehensive agenda ensures participants will gain important\, practical\, lifelong skills that they can put to immediate use. \nCourse Schedule: \nDecember 1st\, 2020\, 1:00-3:30 PM\nDecember 3rd\, 2020\, 1:00-3:30 PM\nDecember 8th\, 2020\, 1:00-3:30 PM \nThe following topics will be covered in three 2.5 hour sessions virtually: \nOrganizing Content\nHandling Questions\nProjecting Confidence\nBeing Persuasive\nManaging Nervousness\nUsing Technical Visuals\nBuilding a Cohesive Story \nSession I \nIntroduction\nSharing communication challenges\nUnderstanding the Listener’s Needs\nUnderstanding the Communication Environment\nIdentifying Theme\nOrganizing Content\nBeing Persuasive \nSession II\nControlling Nervousness\nUsing Notes\nWorking with Visual Aids\nBest Practices for Presenting Virtually\nHandling Questions \nSession III\nPractice Strategies\nDelivering Presentation to Group for feedback and coaching
URL:https://www.masslifesciences.com/event/presenting-with-persuasion-clarity-strength-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T080000
DTEND;TZID=America/New_York:20201203T170000
DTSTAMP:20260408T152325
CREATED:20200508T161051Z
LAST-MODIFIED:20200528T122020Z
UID:11656-1606809600-1607014800@www.masslifesciences.com
SUMMARY:Medical Affairs Congress
DESCRIPTION:Leading strategies to advance medical science communications\, engage with kols compliantly\, conduct effective investigator studies and ensure excellence throughout your medical affairs team. \nWelcome to the Medical Affairs Congress! This year\, we are combining and replacing four of our 2019 conferences: \n\nMedical Affairs\nExpanded Access Programs\nInvestigator Initiated Research Studies\nPublication Planning\n\nThe new and improved Medical Affairs Congress is a robust\, multi-tracked program Join us in Boston this May for a 360 degree view of the medical affairs landscape that brings together Investigator Initiated Sponsored Research (IISR)\, Expanded Access Programs (EAP) and Medical Publications & Communications. \nRemember to use your discount code MLS400 to save $400* off a standard registration. \n*Discount applies to standard rates only and may not be combined with other offers\, category rates\, promotions or applied to an existing registration. Offer not valid on workshop only or academic/non-profit registrations.
URL:https://www.masslifesciences.com/event/medical-affairs-congress-2/
LOCATION:Aloft Boston Seaport District\, 401-403 D Street\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201130T130000
DTEND;TZID=America/New_York:20201204T153000
DTSTAMP:20260408T152325
CREATED:20200825T133738Z
LAST-MODIFIED:20200825T133738Z
UID:12210-1606741200-1607095800@www.masslifesciences.com
SUMMARY:From Molecule To Market: R&D And Regulatory Considerations
DESCRIPTION:This MassBioEd online course builds on the business overview of “The Business of Biotech 101” course. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry\, this course delivers an outline of Clinical\, Regulatory\, and Quality considerations and practices. Students will be provided foundational information about the BioPharma industry and regulations via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share and phases of development. \nGuest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will review Research and Development processes and considerations from pre-clinical through market approval. \nCourse Schedule: \nMonday\, November 30th\, 2020\, 1:00 PM – 03:30 PM\nWednesday\, December 2nd\, 2020\, 1:00 PM – 03:30 PM\nFriday\, December 4th\, 2020\, 1:00 PM – 03:30 PM
URL:https://www.masslifesciences.com/event/from-molecule-to-market-rd-and-regulatory-considerations/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201130T113000
DTEND;TZID=America/New_York:20201130T123000
DTSTAMP:20260408T152325
CREATED:20201116T152605Z
LAST-MODIFIED:20201116T152605Z
UID:12732-1606735800-1606739400@www.masslifesciences.com
SUMMARY:Angel Investor Tax Credit Program - Info Session
DESCRIPTION:The Angel Investor Tax Incentive Credit program is offered to angel investors interested in funding early-stage companies engaged in life sciences research and development\, commercialization and manufacturing in Massachusetts. The program provides a taxpayer investor a credit of 20% of the qualifying investment\, or 30% if the business is located in a gateway municipality. Learn more about investors and businesses eligibility requirement as well as program details during this informative session.
URL:https://www.masslifesciences.com/event/angel-investor-tax-credit-program-info-session/
LOCATION:Online\, online
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201123T120000
DTEND;TZID=America/New_York:20201123T123000
DTSTAMP:20260408T152325
CREATED:20201014T154733Z
LAST-MODIFIED:20201014T154733Z
UID:12497-1606132800-1606134600@www.masslifesciences.com
SUMMARY:Emerging Business Models in Digital Health
DESCRIPTION:In this Harvard Medical School webinar\, Bill Evans\, CEO & Managing Director of Rock Health\, will examine emerging business models and the state of digital health in a very dynamic clinical\, reimbursement and regulatory environment. Amidst the coronavirus pandemic\, adoption of digital tools has accelerated with use cases expanding across the health care industry (including health systems\, payers and biopharma and devices companies). FDA approvals for digital therapeutics and the $38 billion Teladoc-Livongo merger represent significant milestones in the maturation of the digital health sector.
URL:https://www.masslifesciences.com/event/emerging-business-models-in-digital-health/
LOCATION:Online\, online
END:VEVENT
END:VCALENDAR